RIPK4 was a critical molecule possessing high metastatic potential for PC patients characterized by high carcinoembryonic antigen (CEA) and cancer antigen 125-positive (CA125+)/CA19-9 levels. The gene discussed is MUC16; the disease is pachyonychia congenita.